The Korean journal of internal medicine · 2014
Cryptococcal meningitis in a patient with chronic hepatitis C treated with pegylated-interferon and ribavirin.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lee Tae-Hee, Lee Kee-Ook, Kim Yong-Seok, Kim Sun-Moon, Huh Kyu-Chan, Choi Young-Woo, Kang Young-Woo
Аннотация
Various adverse events have been reported during combination therapy with pegylated (PEG)-interferon-α and ribavirin, although opportunistic infections, especially cryptococcal meningitis, are very rare. A 61-year-old woman complained of headaches and a fever during treatment of a chronic hepatitis C virus (HCV) infection. She had been treated for 7 months. Her headaches were refractory to analgesics, and she developed subtle nuchal rigidity. The cerebral spinal fluid (CSF) revealed a white blood cell count of 205/mm(3), 51 mg/dL protein, 35 mg/dL glucose, and negative Cryptococcus antigen. The CSF culture resulted in no growth. Five days later, the CSF was positive for Cryptococcus antigen. We administered amphotericin B and flucytosine, followed by fluconazole. Approximately 2 months later, she was discharged. For the first time, we report a case of cryptococcal meningitis during the treatment of chronic HCV with PEG-interferon-α and ribavirin.
Предметные рубрики MeSH
Antifungal AgentsAntiviral AgentsCryptococcus neoformansDrug Therapy, CombinationFemaleHepatitis C, ChronicHumansImmunocompromised HostInterferon alpha-2Interferon-alphaMeningitis, CryptococcalMiddle AgedOpportunistic InfectionsPolyethylene GlycolsRecombinant ProteinsRibavirinTime FactorsTreatment Outcome